Neuroscience

A newly developed drug stabilizes dopamine and serotonin levels using a novel mechanism. It effectively treats psychosis in patients with schizophrenia, and researchers are testing its efficacy for Parkinson’s disease as well.

Scientists identified a new sex-specific pain circuit in the brain, laying the groundwork for developing better pain-relieving drugs for both sexes.

Spending an hour every day listening to a low-pitched thrum and gazing at blinking lights may help prevent structural changes in the brain and cognitive impairments associated with Alzheimer’s disease.

LIVE June 17th, 2021 at 2:30 PM ET
This webinar will discuss recent disease and drug discoveries enabled through screening CRISPR-modified stem cells.

LIVE May 25th, 2021 at 10:30 AM ET
This webinar will discuss new drug delivery approaches to overcoming the blood-brain barrier.

New discoveries suggest it is on par with therapeutics and speeds the process of recovery and adoption of personalized treatment

Bioasis announces publication evaluating CNS delivery of siRNA via the company’s xB³ platform

Making the rounds of brain-related therapeutic and diagnostic R&D, with a focus on neurodegenerative disease and dementia

Researchers add analysis to the mix to move beyond anecdotes

Combining machine learning and EEG may have identified an imaging biomarker for better treating PTSD and MDD